A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Parkinson's Disease Mild Cognitive Impairment (PD-MCI)
Clinical trial NCT04476017 · COMPLETED
Trial details
- NCT number
- NCT04476017
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-31
- Primary completion
- 2022-03-25
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.